Search

for
Search:

Research

5 / 135 results

The Efficacy and Safety of 17α-Estradiol (Ell-Cranell Alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study

research The Efficacy and Safety of 17α-Estradiol (Ell-Cranell® alpha 0.025%) Solution on Female Pattern Hair Loss: Single Center, Open-Label, Non-Comparative, Phase IV Study

21 citations , January 2012 in “Annals of Dermatology”

This study reported that Ell-Cranell® alpha 0.025% solution significantly increased hair counts and diameter in Korean women with female pattern hair loss over an 8-month period, showing both efficacy and safety.

research Current and Future Medical Treatment of Androgenetic Alopecia

September 2017

Treatments for hair loss vary, but cell-based options may be the future.

Evidence-Based Guideline for the Treatment of Androgenetic Alopecia in Women and Men – Short Version

research Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version

145 citations , November 2017 in “Journal of The European Academy of Dermatology and Venereology”

This guideline review by the European Dermatology Forum evaluates current treatments for androgenetic alopecia but reports no new research findings, aiming to assist dermatologists in selecting safe and effective therapies.

research Updates in Treatment for Androgenetic Alopecia

January 2025 in “Annals of Dermatology”

This review discusses current and emerging treatments for androgenetic alopecia, covering mechanisms, efficacy, and safety of both androgen-targeted and non-androgen-targeted approaches, but reports no new clinical results.

research Experimental and early investigational drugs for androgenetic alopecia

11 citations , July 2017 in “Expert Opinion on Investigational Drugs”

This review discusses current and emerging therapeutic strategies for androgenetic alopecia, noting limited evidence but suggesting areas such as prostaglandin analogs, PRP, and progenitor cell therapies as promising future directions.

View more "ell-cranell alpha 0 025 percent" in research →

Community Join

3 / 1000+ results

community Guys, we finally have an alternative to finasteride

in Research/Science 263 upvotes 1 year ago

A combination of pyrilutamide, minoxidil, and alfatradiol is proposed as an effective alternative to finasteride for treating mild to moderate hair loss, claiming to stabilize hair loss and improve thickness without finasteride's side effects. Some users are skeptical about the effectiveness and approval of these treatments, while others are interested in trying them due to finasteride's side effects.

community Kintors 1% Pyrilutamide comes in October/November

in Treatment 21 upvotes 2 years ago

Kintor's 1% Pyrilutamide will be released in October/November. The user cannot tolerate finasteride.

community Why is the general consensus that if you can’t tolerate 5AR Inhibitors you’re “cooked”?

in Research/Science 15 upvotes 11 months ago

Alternatives to finasteride for hair loss include minoxidil, alfatrodial, fluridil, pyrilutamide, and Nizoral. These treatments may not be as effective as finasteride but can help slow hair loss progression.

View more "ell-cranell alpha 0 025 percent" in community →

Learn

1 / 801 results

learn Overview

View more "ell-cranell alpha 0 025 percent" in learn →

Experts

3 / 3 results

Clinics

2 / 2 results